FENC — Fennec Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $383.89m
- $342.64m
- $44.64m
Fennec Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Fennec Pharmaceuticals Q1 Product Sales USD 8.8 Million
Fennec Pharmaceuticals Inc expected to post a loss of 9 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Veren, CME Group, Cognizant
U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group
Fennec Pharma falls on surprise Q4 loss
Fennec Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary
Fennec Pharmaceuticals Inc expected to post earnings of 17 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Equifax, Microstrategy, Netflix
Fennec Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Fennec Pharmaceuticals Reports Q3 2024 Financial Results And Provides Business Update
Fennec Pharmaceuticals Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Fennec Pharmaceuticals Strengthens Executive Leadership Team With Three Key Appointments To Accelerate The Company’S Next Stage Of Growth
U.S. RESEARCH ROUNDUP-Agenus, Guardant Health, Zoetis
Fennec Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Fennec Pharmaceuticals Inc expected to post a loss of 3 cents a share - Earnings Preview
Fennec Pharmaceuticals Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary